There are 1 Embomycin B from 1 suppliers on EC21.com
Related Searches : acupuncture needle , acupuncture , needle , moxa , cupping , needles , massage , metal handle
Price
Supplier Info.
Report Item
Your report on Product(s) will be sent to EC21 Administrators once submitted.
Then, Administrators will investigate and then take appropriate actions.
Contact Supplier
Storage temperature from light, -20 C storage Transportation conditions: ultra-low temperature ice bag transportation If possible, you try to configure the solution on the day of use and use it on that day. However, if you need to preprepare the reserve solution, we recommend that you keep aliquots of the solution in a sealed vial of the-20 C solution. Usually, they can be used for up to a month. Before use and before opening the sample bottle, we recommend that you have your product equilibrate at room temperature for at least 1 hour. Need more advice on solubility, usage, and handling? Please visit our Frequently Asked Questions (FAQ) page for more details. Sensitivity is sensitive to light The melting point is 94 C
Eomycin (epothilone) is a class of macrolide compounds first reported by G. Hofle et al by the German National Center for Biotechnology (GBF) in 1993. Eomycin can be isolated from the fermentation broth of the myxobacterium suborder, and its main components are Epothilone A and B.
Their activities similar to paclitaxel tubulin polymerization and inhibition of microtubule depolymerization make it a new generation of anti-antimitotic drugs, similar to paclitaxel drugs, can bind with tubulin to make cancer cells unable to undergo mitosis, and then cancer cells to produce apoptosis. Ebomycin is superior to paclitaxel in antitumor spectrum, antitumor activity, safety, water solubility and synthetic methods, and is expected to develop into a more effective antitumor drug than paclitaxel.
It shares the same mechanism of action as paclitaxel to inhibit tumor cell growth, and exhibits potent anticancer activity against both multidrug-resistant tumor cells and paclitaxel-resistant tumor cells.
| Registration Date | 2023/11/30(Year/Month/Date) |
|---|---|
| Buyer / Seller in EC21 | Seller |
| Business Type | Trading Company |
| Year established | 2019 |
| Employees total | 11 - 50 |
| Annual revenue | USD 500,001 - 1,000,000 |
| Company | Hubei Micro Pharmaceutical Co.,Ltd |
|---|---|
| Address | NO.1111, YONGLI INTERNATIONAL BUILDING, HONGSHAN DISTRICT, WUHAN CITY, HUBEI PROVINCE, CHINAWuhanHubeiChina |
| Phone | 86 - 021 - 61090366 |
| Contact | billy chu |